Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD

NCT: NCT07539324 · NOT_YET_RECRUITING

NCT IDNCT07539324
StatusNOT_YET_RECRUITING
Start Date2026-04-15
Completion2032-07-31

Brief Summary

This study aimes to compare the clinical outcomes of drug-coated balloon-based percutaneous coronary intervention (DCB-based PCI) and drug-eluting stent-based percutaneous coronary intervention (DES-based PCI) in patients with multivessel coronary artery lesions measuring 2.25 mm to 4.0 mm in diameter through a prospective, multicenter, active-controlled, randomized, investigator-initiated clinical trial.

Frequently Asked Questions

What is Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD?

Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD is a clinical trial registered under NCT07539324. Current status: NOT_YET_RECRUITING.

What is the status of NCT07539324?

The current status of NCT07539324 (Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD) is: NOT_YET_RECRUITING.

When did Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD start?

Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD started on 2026-04-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑